BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7817704)

  • 1. Red cells, HLA and platelet antibody formation in patients with multiple transfusions.
    Chow MP; Hu HY; Lyou JY; Lin JS; Yung CH; Lee A; Lee TD
    Acta Haematol; 1994; 92(2):57-60. PubMed ID: 7817704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
    Lo SC; Lin DT; Lin SW; Chang JS
    J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HLA antibody screening with extracted platelet HLA antigens by the mixed passive hemagglutination method.
    Araki N; Shibata Y; Inaba H; Nose Y; Sakata N; Ito K
    Vox Sang; 1995; 69(3):222-30. PubMed ID: 8578735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test.
    Kurz M; Knöbl P; Kalhs P; Greinix HT; Höcker P; Panzer S
    Transfusion; 2001 Jun; 41(6):771-4. PubMed ID: 11399818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
    Schnaidt M; Northoff H; Wernet D
    Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of enzyme treatment to enhance reactivity of HLA and platelet-specific antibodies in solid-phase RBC adherence assays.
    Leach MF; AuBuchon JP
    Transfusion; 2002 Apr; 42(4):476-80. PubMed ID: 12076296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.
    Vongchan P; Nawarawong W; Linhardt RJ
    Am J Clin Pathol; 2008 Sep; 130(3):455-66. PubMed ID: 18701420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed passive hemagglutination with soluble platelet antigens.
    Shibata Y; Juji T; Tohyama H; Sakamoto H; Ozawa N; Kano K
    Int Arch Allergy Appl Immunol; 1984; 74(1):93-6. PubMed ID: 6584406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-specific antibodies in transfused patients.
    Uhrynowska M; Zupańska B
    Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
    Godeau B; Fromont P; Seror T; Duedari N; Bierling P
    Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.